Correction to: Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
Crossref DOI link: https://doi.org/10.1007/s12325-021-01815-6
Published Online: 2021-06-22
Published Print: 2021-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Perumal, Jai
Balabanov, Roumen
Su, Ray
Chang, Roger
Balcer, Laura
Galetta, Steven
Campagnolo, Denise I.
Avila, Robin
Lee, Lily
Rutledge, Danette
Fox, Robert J.
Text and Data Mining valid from 2021-06-22
Version of Record valid from 2021-06-22
Article History
First Online: 22 June 2021